Upregulation of thrombospondin-1(TSP-1) and its binding partners, CD36 and CD47, in sporadic inclusion body myositis

J Neuroimmunol. 2007 Jul;187(1-2):166-74. doi: 10.1016/j.jneuroim.2007.04.022. Epub 2007 Jun 18.

Abstract

The TSP1/CD36/CD47-complex is involved in T cell expansion and inflammatory responses to beta-amyloid, both relevant to IBM. We report on the mRNA and protein expression of TSP1/ CD36 /CD47-complex in IBM muscles and in human myoblasts after cytokine stimulation. The TSP1/CD36 /CD47 was upregulated in IBM. TSP1 immunolocalized to the connective tissue contiguous to inflammation and CD36/CD47 on the myofibers and CD8+ cells. Further, TNF-alpha upregulated the production of TSP1 and CD47 by myoblasts. The TSP-complex is another inflammatory mediator associated with chronic inflammation in IBM that may perpetuate the immune responses to local antigens in response to TNF-alpha.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD36 Antigens / genetics
  • CD36 Antigens / metabolism*
  • CD47 Antigen / genetics
  • CD47 Antigen / metabolism*
  • Fibroblasts / drug effects
  • Fibroblasts / metabolism
  • Humans
  • Immunohistochemistry / methods
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Myositis, Inclusion Body / metabolism*
  • Myositis, Inclusion Body / pathology
  • Myositis, Inclusion Body / physiopathology*
  • RNA, Messenger / biosynthesis
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Statistics, Nonparametric
  • Thrombospondin 1 / genetics
  • Thrombospondin 1 / metabolism*
  • Tumor Necrosis Factor-alpha / pharmacology
  • Up-Regulation / drug effects
  • Up-Regulation / physiology*

Substances

  • CD36 Antigens
  • CD47 Antigen
  • RNA, Messenger
  • Thrombospondin 1
  • Tumor Necrosis Factor-alpha